Interesting ImagesFDG PET/CT and MRI in Primary Spinal Cord GlioblastomaShen, Guohua MD*; Ma, Huan MS†; Pan, Lili MS*; Su, Minggang MD*; Kuang, Anren MD*Author Information From the *Department of Nuclear Medicine, Laboratory of Clinical Nuclear Medicine, West China Hospital of Sichuan University †Sichuan New Radiopharmaceuticals Technology Co, Ltd, Chengdu, Sichuan, People's Republic of China. Received for publication June 19, 2019; revision accepted July 28, 2019. Conflicts of interest and sources of funding: This study was supported by National Natural Science Foundation of China (grant no. 81471692 and grant no. 81901776), Sichuan Science and Technology Program (grant no. 2018HH0081), project funded by China Postdoctoral Science Foundation (grant No. 2019M650245), and Post-Doctor Research Project, West China Hospital, Sichuan University (grant no. 18HXBH070). None declared to all authors. Correspondence to: Anren Kuang, MD, Department of Nuclear Medicine, Laboratory of Clinical Nuclear Medicine, West China Hospital of Sichuan University, No. 37 Guoxue Alley, Chengdu 610041, People's Republic of China. E-mail: email@example.com. Online date: October 31, 2019 Clinical Nuclear Medicine: March 2020 - Volume 45 - Issue 3 - p e144-e145 doi: 10.1097/RLU.0000000000002800 Buy Metrics Abstract Glioblastoma is the most common primary malignant tumor of the central nervous system, most of which occur in the brain. Primary spinal cord glioblastoma is extremely rare. A 47-year-old woman presented with recurrent and progressive paresthesia and paralysis of right lower extremity. MR examination revealed a marked nodular enlargement of spinal cord at the T12 level, showing heterogeneous enhancement. FDG PET/CT showed this intraspinal lesion with high FDG uptake. Imaging findings indicated a possible diagnosis of malignant neoplasm. Surgical resection was performed, and the pathologic results confirmed a primary spinal cord glioblastoma. Copyright © 2020 Wolters Kluwer Health, Inc. All rights reserved.